Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-17

Clinical Trial Update: Sup-ER Splint for Children With Birth Related Brachial Plexus Injury [NA]

View source ↗

Summary

The Sup-ER Splint trial for birth-related brachial plexus injury in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Birth Related Brachial Plexus Injury, Obstetrical Brachial Plexus Palsy | NA | Status: WITHDRAWN